Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.
Clinical trial NCT05728008 · COMPLETED
Trial details
- NCT number
- NCT05728008
- Sponsor
- IRCCS San Raffaele
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-05
- Primary completion
- 2022-06-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.